Medicine and Dentistry
Maturity Onset Diabetes of the Young
94%
Diabetes
67%
Helicobacter Infection
47%
Subtilisin
47%
Kexin
47%
Growth Differentiation Factor 15
47%
Infection
47%
Glycemic Control
47%
Taste Bud
47%
Sucralose
47%
Hyperglycemia
47%
Helicobacter pylori
47%
Cell Signaling Pathway
47%
Knockout Mouse
47%
AMPK Signaling
47%
Patient with Diabetes
47%
Nonalcoholic Fatty Liver
47%
AMP-Activated Protein Kinase
47%
Impaired Glucose Tolerance
47%
Metabolic Syndrome
47%
Non-Alcoholic Fatty Liver Disease
47%
Sarcopenia
47%
Glycogen Synthesis
31%
Frailty
29%
Urea Breath Test
20%
Insulin Resistance
20%
Glucose Tolerance
20%
Impaired Fasting Glucose
20%
Biological Marker
17%
Fat Droplet
15%
High Fat Food
15%
Fatty Liver
15%
Disease Exacerbation
15%
RNA Editing
15%
Insulin Signaling
15%
Glucose Intolerance
15%
Gluconeogenesis
15%
Inosine
15%
Adenosine Deaminase
15%
Adenosine
15%
Pyruvic Acid
15%
Chronic Disease
15%
Dyslipidemia
15%
Body Mass Index
15%
Cancer
13%
Diabetes Mellitus
12%
Hemoglobin A1c
11%
Oral Antidiabetic Agent
10%
Enzyme Linked Immunosorbent Assay
10%
Patient with Type 2 Diabetes
8%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Liver
100%
Nonalcoholic Fatty Liver
82%
Biological Marker
70%
Insulin Resistance
67%
Non Insulin Dependent Diabetes Mellitus
47%
Knockout Mouse
47%
Unsaturated Fatty Acid
47%
Kexin
47%
Helicobacter pylori
47%
STAT3 Protein
47%
Subtilisin
47%
Hedgehog
47%
Infection
47%
Helicobacter Infection
47%
Mouse Mutant
47%
Serine Proteinase
47%
Glucagon Like Peptide 1 Receptor Agonist
47%
Familial Hypercholesterolemia
47%
Hemoglobin A1c
42%
Oleic Acid
35%
Glucagon-Like Peptide-1
28%
Diseases
27%
Alanine Aminotransferase
23%
C Reactive Protein
23%
High Density Lipoprotein Cholesterol
23%
Triacylglycerol
23%
Urea Breath Test
20%
Fatty Acid
17%
Adenosine Deaminase
15%
Chronic Disease
15%
Glucose Intolerance
15%
Fat Droplet
15%
Inosine
15%
Pyruvic Acid
15%
Adenosine
15%
Dyslipidemia
15%
Disease Exacerbation
15%
Wild Type Mouse
15%
Cell Viability
11%
Low Density Lipoprotein Cholesterol
11%
Oral Antidiabetic Agent
10%
Retrospective Study
9%
Liraglutide
9%
Clinical Study
9%
Dulaglutide
9%
Antidiabetic Agent
9%
Genetic Disorder
5%
Linoleic Acid
5%
Binding Site
5%
Coronary Artery Disease
5%
Keyphrases
Hedgehog Proteins
94%
Homozygous Familial Hypercholesterolemia (HoFH)
47%
Proprotein Convertase Subtilisin/kexin Type 9 Inhibitors
47%
Mini
47%
Type 2 Diabetes Mellitus (T2DM)
47%
Unsaturated Fatty Acids
47%
Pre-diabetes (pre-DM)
47%
Secretogranin III
47%
Sucralose
47%
Taste Receptors
47%
Obese Sarcopenia
47%
HepG2 Cells
47%
Hepassocin
47%
Protein Level
47%
Signal Transducer and Activator of Transcription 3
47%
L6 Myoblasts
23%
Oleic Acid
20%
Senior Fitness Test
17%
Impaired Fasting Glucose
15%
New-onset Diabetes
15%
Impaired Glucose Tolerance
15%
Normal Glucose Tolerance
15%
Diabetes
15%
Low-density Lipoprotein Cholesterol (LDL-C)
11%
Myoblast Proliferation
11%
Fasting Plasma Glucose
10%
Protein Concentration
10%
Fatty Acids
10%
GluR
9%
Skeletal muscle Index
8%
Remote Infection
7%
Intracellular Lipid Accumulation
6%
Non-alcoholic Fatty Liver Disease (NAFLD)
6%
Cell Viability
6%
Protective Effect
6%
Real-world Evidence Study
6%
Acid Treatment
6%
Treatment Experience
5%
Premature Coronary Artery Disease
5%
Metabolic Dysregulation
5%
Liver Disease Models
5%
Cardiac Events
5%
Taiwan
5%
Cholesterol-lowering Agents
5%
Inhibitor Therapy
5%
Clinical Trials
5%
Rare Genetic Disease
5%
C-reactive Protein
5%
Low-density Lipoprotein Cholesterol Level
5%
High-density Lipoprotein Cholesterol (HDL-C)
5%
